国产91长腿美女在线观看._国产私人影院在线播放_激情销魂乳妇奶水小说_中文日韩精品欧美一区_黄色软件app大全免费下载_国产狂喷水潮免费网站WWW_亚洲欧美高清精品a∨_國產一區二區三區亂碼_蕉综合色狠狠_免费人成网站在线观看高清
<noframes id="iiuoy"><tfoot id="iiuoy"></tfoot></noframes>
<fieldset id="iiuoy"></fieldset>
<code id="iiuoy"><dd id="iiuoy"></dd></code>
<code id="iiuoy"><xmp id="iiuoy"></xmp></code>
Other Affiliated Sites
Techdow Pharma China
Techdow Pharma UK
Techdow Pharma Poland
Techdow Pharma Italy
Techdow Pharma Spain
Techdow Pharma Germany
Techdow Pharma US
Cytovance Biologics
SPL
Simplified Chinese
Traditional Chinese
About Hepalink
Group Profile
Corporate Philosophy
Milestones
Leadership Team
Scientific Advisory Board
Our Businesses
Heparin Business
Global Industrial Chain
Global Heparin Injections Business
Product Profile
CDMO Services
Innovative Drugs
Global Manufacturing
Company News
Investor Relations
Corporate Governance
Disclosures
Stock Information
IR Events
IR Contact
Join Us
Career Development
Job Opportunities
Campus Recruitment
Contact Us
Create Value for Investors Through
Safe and Stable Operations
Corporate Governance
Disclosures
Stock Information
IR Events
IR Contact
Disclosures
A-Share Information
H-Share Information
Financial Reports
Announcements
2025.04.02
海普瑞：關于舉行2024年度業(yè)績說明會的公告
2025.03.28
海普瑞：年度關聯(lián)方資金占用專項審計報告
2025.03.28
海普瑞：年度股東大會通知
2025.03.28
海普瑞：內(nèi)部控制自我評價報告
2025.03.28
海普瑞：內(nèi)部控制審計報告
2025.03.28
海普瑞：關于修訂第二期員工持股計劃和第三期員工持股計劃的公告
2025.03.28
海普瑞：關于使用自有資金購買理財產(chǎn)品及進行現(xiàn)金管理的公告
2025.03.28
海普瑞：關于開展以套期保值為目的的外匯衍生品交易的可行性分析報告
2025.03.28
海普瑞：關于會計師事務所2024年度履職情況評估報告
2025.03.28
海普瑞：關于公司2024年計提資產(chǎn)減值準備的公告
第一頁
上一頁
1
2
3
4
5
下一頁
最后一頁
About Hepalink
Group Profile
Corporate Philosophy
Milestones
Leadership Team
Scientific Advisory Board
Our Businesses
Heparin Business
CDMO Services
Innovative Drugs
Global Manufacturing
Company News
Investor Relations
Corporate Governance
Disclosures
Stock Information
IR Events
IR Contact
Join Us
Career Development
Job Opportunities
Campus Recruitment
Contact Us
Official WeChat Account
Legal Statement
·
Environmental Disclosure
Copyright ? 2024 Hepalink Group. All Rights Reserved.
